Search results

Found 48 pages
AUTHOR: Michael Day

Results per page

10 20 50 100

Sort by

Relevance Date

26 Mar 2008:

Many group-randomised cancer trials have statistical flaws

Most group-randomised trials for the prevention and control of cancer use questionable statistical methods, suggests a review of studies published between 2002 and 2006. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/many_group-randomised_cancer_trials_have_statistical_flaws_987421

12 Jul 2007:

Knock for long-term HRT in older women

Hormone replacement therapy should not be prescribed to older women who are many years past menopause because it likely to increase rather than reduce their risk of heart disease, experts say in the online version of this week’s British Medical

by Michael Day

https://www.pharmatimes.com/news/knock_for_long-term_hrt_in_older_women_990378

9 Oct 2007:

UK government waves through inter-species embryos for research

The British Government has bowed to pressure from MPs and scientists and will allow the use of inter-species embryos for research purposes. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/uk_government_waves_through_inter-species_embryos_for_research_991068

8 Mar 2007:

Power struggle undermining fight against HIV and TB

A power struggle between scientists in the HIV and tuberculosis communities is undermining the fight against both diseases, according to a report in the latest issue of Nature Medicine. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/power_struggle_undermining_fight_against_hiv_and_tb_989505

19 Nov 2007:

New R&D approaches desperately needed for TB drugs, report says

For the first time in decades, new drugs for tuberculosis are under development. However, the relatively small number of pipeline compounds remains a cause for concern given the global emergence of drug-resistant TB, a new report warns. - News -

by Michael Day

https://www.pharmatimes.com/news/new_r_and_d_approaches_desperately_needed_for_tb_drugs,_report_says_991398

2 May 2008:

Drug-resistant TB cases on the increase in UK, says report

The incidence of drug-resistant tuberculosis is rising in the UK, researchers warn this morning. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/drug-resistant_tb_cases_on_the_increase_in_uk,_says_report_987146

17 May 2007:

MRC to step up role in pharma research

The UK’s Medical Research Council will step up its role in pharmaceutical research, after indicating that it expects a lion’s share of the research budget increases announced by the Treasury. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/mrc_to_step_up_role_in_pharma_research_989886

28 Mar 2008:

Tight FDA deadlines increase drug safety concerns

Drugs fast-tracked by the US Food and Drug Administration are three times more likely to be withdrawn later than medicines approved at normal speed, according to a Harvard University study. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/tight_fda_deadlines_increase_drug_safety_concerns_987400

28 Aug 2007:

Doctor slams Alzheimer's Society for ties with pharma

The Alzheimer’s Society has come under fire from a senior doctor who has accused it of working too closely with the pharmaceutical industry in contesting the National Institute for Health and Clinical Excellence’s partial ban on the use of

by Michael Day

https://www.pharmatimes.com/news/doctor_slams_alzheimers_society_for_ties_with_pharma_990725

9 Oct 2008:

AIDS and cervical cancer pioneers scoop Nobel prize

Leading industry and academic figures have hailed this year's Nobel Prize for medicine, which is shared for pivotal advances in AIDS/HIV and cervical cancer. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/aids_and_cervical_cancer_pioneers_scoop_nobel_prize_986630